Bank of America’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $48 | Sell |
|
|||||
|
2024
Q3 | $1.52K | Sell |
|
|||||
|
2024
Q2 | $93.5K | Sell |
|
|||||
|
2024
Q1 | $181K | Buy |
|
|||||
|
2023
Q4 | $78.1K | Buy |
|
|||||
|
2023
Q3 | $269 | Sell |
|
|||||
|
2023
Q2 | $218 | Sell |
|
|||||
|
2023
Q1 | $2.98K | Sell |
|
|||||
|
2022
Q4 | $4.13K | Sell |
|
|||||
|
2022
Q3 | $7K | Sell |
|
|||||
|
2022
Q2 | $24K | Sell |
|
|||||
|
2022
Q1 | $34K | Sell |
|
|||||
|
2021
Q4 | $139K | Buy |
|
|||||
|
2021
Q3 | $139K | Sell |
|
|||||
|
2021
Q2 | $180K | Sell |
|
|||||
|
2021
Q1 | $309K | Buy |
|
|||||
|
2020
Q4 | $153K | Sell |
|
|||||
|
2020
Q3 | $491K | Buy |
|
|||||
|
2020
Q2 | $202K | Sell |
|
|||||
|
2020
Q1 | $128K | Buy |
|
|||||
|
2019
Q4 | $104K | Buy |
|
|||||
|
2019
Q3 | $142K | Buy |
|
|||||
|
2019
Q2 | $75K | Buy |
|
|||||
|
2019
Q1 | $69K | Sell |
|
|||||
|
2018
Q4 | $98K | Buy |
|
|||||
|
2018
Q3 | $68K | Buy |
|
|||||
|
2018
Q2 | $38K | Buy |
|
|||||
|
2018
Q1 | $16K | Sell |
|
|||||
|
2017
Q4 | $14K | Buy |
|
|||||
|
2017
Q3 | $11K | Buy |
|
|||||
|
2017
Q2 | $5K | Sell |
|
|||||
|
2017
Q1 | $13K | Buy |
|
|||||
|
2016
Q4 | $8K | Buy |
|